$INTC
Intel Corp

2022 Q4 Form 10-Q Financial Statement

#000005086322000038 Filed on October 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q4
Revenue $15.34B
YoY Change -25.28%
Cost Of Revenue $8.803B
YoY Change -7.52%
Gross Profit $6.535B
YoY Change -40.64%
Gross Profit Margin 42.61%
Selling, General & Admin $1.744B
YoY Change -10.2%
% of Gross Profit 26.69%
Research & Development $4.302B
YoY Change 6.25%
% of Gross Profit 65.83%
Depreciation & Amortization $3.252B
YoY Change 5.79%
% of Gross Profit 49.76%
Operating Expenses $6.710B
YoY Change 12.0%
Operating Profit -$175.0M
YoY Change -103.49%
Interest Expense $114.0M
YoY Change -55.81%
% of Operating Profit
Other Income/Expense, Net $138.0M
YoY Change -360.38%
Pretax Income -$188.0M
YoY Change -103.62%
Income Tax -$1.207B
% Of Pretax Income
Net Earnings $1.019B
YoY Change -77.96%
Net Earnings / Revenue 6.64%
Basic Earnings Per Share $0.25
Diluted Earnings Per Share $0.25
COMMON SHARES
Basic Shares Outstanding 4.118B shares
Diluted Shares Outstanding 4.125B shares

Balance Sheet

Concept 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.56B
YoY Change -22.88%
Cash & Equivalents $4.529B
Short-Term Investments $18.03B
Other Short-Term Assets $6.348B
YoY Change 198.03%
Inventory $12.83B
Prepaid Expenses
Receivables $7.469B
Other Receivables $0.00
Total Short-Term Assets $49.26B
YoY Change -15.87%
LONG-TERM ASSETS
Property, Plant & Equipment $75.76B
YoY Change 19.79%
Goodwill $27.59B
YoY Change 2.33%
Intangibles $6.268B
YoY Change -13.78%
Long-Term Investments $11.00M
YoY Change -31.25%
Other Assets $10.13B
YoY Change 66.9%
Total Long-Term Assets $125.6B
YoY Change 14.32%
TOTAL ASSETS
Total Short-Term Assets $49.26B
Total Long-Term Assets $125.6B
Total Assets $174.8B
YoY Change 3.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.133B
YoY Change 24.12%
Accrued Expenses $18.40B
YoY Change 7.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $2.283B
YoY Change -50.27%
Total Short-Term Liabilities $27.81B
YoY Change 1.28%
LONG-TERM LIABILITIES
Long-Term Debt $37.24B
YoY Change 11.13%
Other Long-Term Liabilities $5.760B
YoY Change 13.59%
Total Long-Term Liabilities $43.00B
YoY Change 11.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.81B
Total Long-Term Liabilities $43.00B
Total Liabilities $70.81B
YoY Change 7.22%
SHAREHOLDERS EQUITY
Retained Earnings $71.02B
YoY Change 4.04%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $99.89B
YoY Change
Total Liabilities & Shareholders Equity $174.8B
YoY Change 3.82%

Cashflow Statement

Concept 2022 Q4
OPERATING ACTIVITIES
Net Income $1.019B
YoY Change -77.96%
Depreciation, Depletion And Amortization $3.252B
YoY Change 5.79%
Cash From Operating Activities $1.030B
YoY Change -82.23%
INVESTING ACTIVITIES
Capital Expenditures -$7.299B
YoY Change -4.36%
Acquisitions
YoY Change
Other Investing Activities $2.725B
YoY Change 4.89%
Cash From Investing Activities -$4.574B
YoY Change -9.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.683B
YoY Change -196.77%
NET CHANGE
Cash From Operating Activities 1.030B
Cash From Investing Activities -4.574B
Cash From Financing Activities 3.683B
Net Change In Cash 139.0M
YoY Change -104.57%
FREE CASH FLOW
Cash From Operating Activities $1.030B
Capital Expenditures -$7.299B
Free Cash Flow $8.329B
YoY Change -37.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2022-10-01
dei Entity Central Index Key
EntityCentralIndexKey
0000050863
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
91417000000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
85294000000 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4127000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4070000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4070000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-10-01
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-06217
dei Entity Registrant Name
EntityRegistrantName
INTEL CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-1672743
dei Entity Address Address Line1
EntityAddressAddressLine1
2200 Mission College Boulevard,
dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95054-1549
dei City Area Code
CityAreaCode
(408)
dei Local Phone Number
LocalPhoneNumber
765-8080
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value
dei Trading Symbol
TradingSymbol
INTC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4127000000 shares
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4127000000 shares
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15338000000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19192000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49012000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58496000000 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8803000000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8446000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27646000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25690000000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
6535000000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
10746000000 usd
us-gaap Gross Profit
GrossProfit
21366000000 usd
us-gaap Gross Profit
GrossProfit
32806000000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4302000000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3803000000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13064000000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11141000000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1744000000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1674000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5296000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4601000000 usd
CY2022Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
664000000 usd
CY2021Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
42000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
-460000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2597000000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
6710000000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5519000000 usd
us-gaap Operating Expenses
OperatingExpenses
17900000000 usd
us-gaap Operating Expenses
OperatingExpenses
18339000000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-175000000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5227000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3466000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
14467000000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-151000000 usd
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1707000000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
4082000000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2370000000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
138000000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-76000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1016000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-328000000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-188000000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6858000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8564000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16509000000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1207000000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-114000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1264000000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1019000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6823000000 usd
us-gaap Net Income Loss
NetIncomeLoss
8678000000 usd
us-gaap Net Income Loss
NetIncomeLoss
15245000000 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.76
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.73
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4118000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4061000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4104000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4055000000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4125000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4086000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4123000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4089000000 shares
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1019000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6823000000 usd
us-gaap Net Income Loss
NetIncomeLoss
8678000000 usd
us-gaap Net Income Loss
NetIncomeLoss
15245000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-436000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-46000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-1178000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-390000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-10000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-13000000 usd
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-37000000 usd
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-38000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-19000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-30000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-44000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-426000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-52000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1171000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-396000000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
593000000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6771000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7507000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14849000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4529000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4827000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
18030000000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
24426000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7469000000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9457000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
12831000000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
10776000000 usd
CY2022Q4 intc Assets Held For Sale
AssetsHeldForSale
56000000 usd
CY2021Q4 intc Assets Held For Sale
AssetsHeldForSale
6942000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6348000000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2130000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
49263000000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
58558000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
75763000000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
63245000000 usd
CY2022Q4 intc Equity Investments
EquityInvestments
5822000000 usd
CY2021Q4 intc Equity Investments
EquityInvestments
6298000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
27591000000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
26963000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6268000000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7270000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10134000000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6072000000 usd
CY2022Q4 us-gaap Assets
Assets
174841000000 usd
CY2021Q4 us-gaap Assets
Assets
168406000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
2283000000 usd
CY2021Q4 us-gaap Debt Current
DebtCurrent
4591000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7133000000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5747000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3421000000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4535000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14976000000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12589000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27813000000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27462000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
37240000000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33510000000 usd
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
3782000000 usd
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
4305000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
361000000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2667000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5760000000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5071000000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
30912000000 usd
CY2021Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
28006000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2051000000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-880000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
71024000000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
68265000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99885000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
95391000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
174841000000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168406000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4827000000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5865000000 usd
us-gaap Net Income Loss
NetIncomeLoss
8678000000 usd
us-gaap Net Income Loss
NetIncomeLoss
15245000000 usd
us-gaap Depreciation
Depreciation
8309000000 usd
us-gaap Depreciation
Depreciation
7357000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2392000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1587000000 usd
us-gaap Restructuring Charges
RestructuringCharges
665000000 usd
us-gaap Restructuring Charges
RestructuringCharges
2597000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1439000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1361000000 usd
intc Non Cash Gains Losses On Equity Investments Net
NonCashGainsLossesOnEquityInvestmentsNet
4075000000 usd
intc Non Cash Gains Losses On Equity Investments Net
NonCashGainsLossesOnEquityInvestmentsNet
1113000000 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
1072000000 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1991000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1618000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2043000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1212000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-485000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1095000000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1912000000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-16000000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-18000000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1577000000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-4062000000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-570000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2077000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-917000000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-948000000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
8808000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7730000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24053000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19145000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11579000000 usd
intc Divestiture Additions To Property Plant And Equipment Held For Sale
DivestitureAdditionsToPropertyPlantAndEquipmentHeldForSale
206000000 usd
intc Divestiture Additions To Property Plant And Equipment Held For Sale
DivestitureAdditionsToPropertyPlantAndEquipmentHeldForSale
1118000000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
31669000000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
30326000000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
35129000000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
22270000000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
4880000000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
444000000 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
6579000000 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2614000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-766000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7046000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19543000000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
341000000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
6103000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4974000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3088000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
500000000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
972000000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1016000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2415000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4488000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4231000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-140000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1349000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-982000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2505000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-298000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2005000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4529000000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7870000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3386000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2693000000 usd
us-gaap Interest Paid Net
InterestPaidNet
315000000 usd
us-gaap Interest Paid Net
InterestPaidNet
271000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3960000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1831000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
101218000000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1019000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-426000000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
399000000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
793000000 usd
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
106000000 usd
CY2022Q4 us-gaap Dividends Common Stock
DividendsCommonStock
3012000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99885000000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
85207000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6823000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-52000000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
427000000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
543000000 usd
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
37000000 usd
CY2021Q3 us-gaap Dividends Common Stock
DividendsCommonStock
2824000000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
90087000000 usd
us-gaap Net Income Loss
NetIncomeLoss
8678000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1171000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
1000000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2392000000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
407000000 usd
us-gaap Dividends Common Stock
DividendsCommonStock
5998000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99885000000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
81073000000 usd
us-gaap Net Income Loss
NetIncomeLoss
15245000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-396000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
1015000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1587000000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2415000000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
377000000 usd
us-gaap Dividends Common Stock
DividendsCommonStock
5645000000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
90087000000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-175000000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5227000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3466000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
14467000000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15338000000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19192000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49012000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58496000000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4055000000 shares
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1019000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6823000000 usd
us-gaap Net Income Loss
NetIncomeLoss
8678000000 usd
us-gaap Net Income Loss
NetIncomeLoss
15245000000 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4118000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4061000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4104000000 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
25000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
19000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
34000000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4125000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4086000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4123000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4089000000 shares
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.76
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.73
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1635000000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1441000000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7030000000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6656000000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4166000000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2679000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
12831000000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
10776000000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
170000000 usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
37000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
315000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
111000000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
114000000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
144000000 usd
us-gaap Interest Expense
InterestExpense
347000000 usd
us-gaap Interest Expense
InterestExpense
463000000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
82000000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1048000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24000000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
138000000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-76000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1016000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-328000000 usd
CY2022Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
220000000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
516000000 usd
CY2021Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
95000000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
288000000 usd
CY2022Q4 us-gaap Severance Costs1
SeveranceCosts1
607000000 usd
CY2021Q3 us-gaap Severance Costs1
SeveranceCosts1
21000000 usd
us-gaap Severance Costs1
SeveranceCosts1
650000000 usd
us-gaap Severance Costs1
SeveranceCosts1
43000000 usd
CY2022Q4 intc Litigation Charges And Other
LitigationChargesAndOther
4000000 usd
CY2021Q3 intc Litigation Charges And Other
LitigationChargesAndOther
16000000 usd
intc Litigation Charges And Other
LitigationChargesAndOther
-1199000000 usd
intc Litigation Charges And Other
LitigationChargesAndOther
2267000000 usd
CY2022Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
53000000 usd
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
89000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
287000000 usd
CY2022Q4 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
664000000 usd
CY2021Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
42000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
-460000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2597000000 usd
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
537000000 usd
CY2021Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
2200000000 usd
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
237000000 usd
CY2022Q4 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-861000000 usd
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-1800000000 usd
CY2021Q3 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
144000000 usd
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
329000000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3600000000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5000000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
11457000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2208000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
4962000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
720000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
861000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
20208000000 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
1185000000 usd
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
2171000000 usd
CY2022Q4 us-gaap Other Investments And Securities At Cost
OtherInvestmentsAndSecuritiesAtCost
4626000000 usd
CY2021Q4 us-gaap Other Investments And Securities At Cost
OtherInvestmentsAndSecuritiesAtCost
4111000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
11000000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
16000000 usd
CY2022Q4 intc Equity Investments
EquityInvestments
5822000000 usd
CY2021Q4 intc Equity Investments
EquityInvestments
6298000000 usd
CY2022Q4 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-244000000 usd
CY2021Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-192000000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-883000000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-345000000 usd
CY2022Q4 intc Observablepriceadjustmentsonnonmarketable
Observablepriceadjustmentsonnonmarketable
67000000 usd
CY2021Q3 intc Observablepriceadjustmentsonnonmarketable
Observablepriceadjustmentsonnonmarketable
79000000 usd
intc Observablepriceadjustmentsonnonmarketable
Observablepriceadjustmentsonnonmarketable
273000000 usd
intc Observablepriceadjustmentsonnonmarketable
Observablepriceadjustmentsonnonmarketable
702000000 usd
CY2022Q4 us-gaap Impairment Of Investments
ImpairmentOfInvestments
45000000 usd
CY2021Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
38000000 usd
us-gaap Impairment Of Investments
ImpairmentOfInvestments
112000000 usd
us-gaap Impairment Of Investments
ImpairmentOfInvestments
111000000 usd
CY2022Q4 intc Other Net Equity Investments
OtherNetEquityInvestments
71000000 usd
CY2021Q3 intc Other Net Equity Investments
OtherNetEquityInvestments
1858000000 usd
intc Other Net Equity Investments
OtherNetEquityInvestments
4804000000 usd
intc Other Net Equity Investments
OtherNetEquityInvestments
2124000000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-151000000 usd
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1707000000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
4082000000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2370000000 usd
CY2022Q4 intc Equity Securities Fvni Gain Loss Net
EquitySecuritiesFVNIGainLossNet
-154000000 usd
CY2021Q3 intc Equity Securities Fvni Gain Loss Net
EquitySecuritiesFVNIGainLossNet
346000000 usd
intc Equity Securities Fvni Gain Loss Net
EquitySecuritiesFVNIGainLossNet
-490000000 usd
intc Equity Securities Fvni Gain Loss Net
EquitySecuritiesFVNIGainLossNet
883000000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
1000000 usd
CY2021Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-46000000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
15000000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-189000000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-153000000 usd
CY2021Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
300000000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-475000000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
694000000 usd
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
941000000 usd
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
6018000000 usd
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
6959000000 usd
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
623000000 usd
CY2022Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
51376000000 usd
CY2021Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
55750000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1965000000 usd
CY2022Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
1965000000 usd
CY2022Q4 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
653000000 usd
CY2022Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
1300000000 usd
CY2022Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
12000000 usd
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell Gross
SecuritiesPurchasedUnderAgreementsToResellGross
2150000000 usd
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell Liability
SecuritiesPurchasedUnderAgreementsToResellLiability
0 usd
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
2150000000 usd
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction
SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction
0 usd
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities
SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities
2150000000 usd
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 usd
CY2022Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross
4115000000 usd
CY2022Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability
0 usd
CY2022Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed
4115000000 usd
CY2022Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction
653000000 usd
CY2022Q4 intc Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash
3450000000 usd
CY2022Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
12000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2237000000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2237000000 usd
CY2022Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
653000000 usd
CY2022Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
1350000000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
234000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2237000000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2237000000 usd
CY2022Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
653000000 usd
CY2022Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
1350000000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
234000000 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1427000000 usd
CY2021Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 usd
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
1427000000 usd
CY2021Q4 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
332000000 usd
CY2021Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
986000000 usd
CY2021Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
109000000 usd
CY2021Q4 us-gaap Securities Purchased Under Agreements To Resell Gross
SecuritiesPurchasedUnderAgreementsToResellGross
1595000000 usd
CY2021Q4 us-gaap Securities Purchased Under Agreements To Resell Liability
SecuritiesPurchasedUnderAgreementsToResellLiability
0 usd
CY2021Q4 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
1595000000 usd
CY2021Q4 us-gaap Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction
SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction
0 usd
CY2021Q4 us-gaap Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities
SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities
1595000000 usd
CY2021Q4 us-gaap Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 usd
CY2021Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross
3022000000 usd
CY2021Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability
0 usd
CY2021Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed
3022000000 usd
CY2021Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction
332000000 usd
CY2021Q4 intc Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash
2581000000 usd
CY2021Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
109000000 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
392000000 usd
CY2021Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
392000000 usd
CY2021Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
332000000 usd
CY2021Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
60000000 usd
CY2021Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
392000000 usd
CY2021Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
392000000 usd
CY2021Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
332000000 usd
CY2021Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
60000000 usd
CY2021Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 usd
CY2022Q4 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
589000000 usd
CY2021Q3 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
55000000 usd
us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
532000000 usd
us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
1536000000 usd
CY2022Q4 intc Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge
NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge
0 usd
CY2021Q3 intc Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge
NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge
0 usd
intc Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge
NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge
0 usd
intc Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge
NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge
0 usd
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="margin-bottom:9pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#0068b5;border-bottom:1pt solid #0068b5;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Note 12 : </span></td><td colspan="3" style="border-bottom:1pt solid #0068b5;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Commitments and Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Commitments</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the third quarter of 2022, we signed a definitive agreement with Brookfield Asset Management (Brookfield). This arrangement represents an equity partnership whereby we and Brookfield own 51% and 49%, respectively, of what will be a newly-formed entity, Arizona Fab LLC (Arizona Fab), which we will fully consolidate into our consolidated financial statements. We expect Arizona Fab to spend up to $30.0 billion of investments in expanded manufacturing infrastructure at our Ocotillo campus in Chandler, Arizona. Generally, contributions will be made to, and distributions will be received from, Arizona Fab based upon our and Brookfield’s proportional ownership, subject to the terms and conditions within the definitive agreement. The definitive agreement includes provisions that require us to utilize Arizona Fab’s expanded manufacturing capacity at specified minimum levels or be subject to penalties. Brookfield’s ownership stake as a non-controlling interest holder in Arizona Fab will be shown as a separate component of equity within our consolidated balance sheet. The transaction with Brookfield is expected to close by the end of 2022, subject to customary closing conditions.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a party to various legal proceedings, including those noted in this section. In the first quarter of 2021, we accrued a charge of $2.2 billion related to litigation involving VLSI, described below. Excluding this charge, management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends; however, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">European Commission Competition Matter</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2001, the European Commission (EC) commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged "conditional rebates and payments" that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged "payments to prevent sales of specific rival products." The EC imposed a fine in the amount of €1.1 billion ($1.4 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to "immediately bring to an end the infringement referred to in" the EC decision.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We appealed the EC decision to the Court of First Instance (which has been renamed the General Court) in July 2009. In June 2014, the General Court rejected our appeal in its entirety. In August 2014, we filed an appeal with the European Court of Justice. In November 2014, Intervener Association for Competitive Technologies filed comments in support of Intel’s grounds of appeal. The Court of Justice issued its decision in September 2017, setting aside the judgment of the General Court and sending the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The General Court appointed a panel of five judges to consider our appeal of the EC’s 2009 decision in light of the Court of Justice’s clarifications of the law, and in January 2022, the General Court issued a decision annulling the EC's findings against Intel regarding rebates as well as the fine imposed on Intel, which was returned to Intel in February 2022. In April 2022, the EC appealed the General Court's decision to the Court of Justice, seeking an order that would require a further proceeding and decision by the General Court. In June 2022, Intel filed a response in opposition to the EC appeal, and in July 2022, the Intervener Association for Competitive Technologies filed a response in opposition to the EC appeal. Given the procedural posture and the nature of this proceeding we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from this matter.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In a related matter, Intel filed applications with the General Court in April 2022 seeking an order requiring the EC to pay Intel approximately €593 million in default interest.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation Related to Security Vulnerabilities</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2017, a Google research team notified Intel and other companies that it had identified security vulnerabilities, now commonly referred to as “Spectre” and “Meltdown,” that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. On January 2, 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Numerous lawsuits have been filed against Intel relating to Spectre, Meltdown, and other variants of the security vulnerabilities that have been identified since 2018. As of October 26, 2022, consumer class action lawsuits against Intel were pending in the United States, Canada, Israel, and Argentina. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by Intel's actions and/or omissions in connection with the security vulnerabilities and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the United States, class action suits filed in various jurisdictions were consolidated for all pretrial proceedings in the United States District Court for the District of Oregon, which entered final judgment in favor of Intel in July 2022 based on plaintiffs' failure to plead a viable claim. Plaintiffs have appealed that decision to the Ninth Circuit Court of Appeals. In Canada, an initial status conference has not yet been scheduled in one case pending in the Superior Court of Justice of Ontario, and a stay of a second case pending in the Superior Court of Justice of Quebec is in effect until November 2022. In Israel, the plaintiff in a lawsuit pending in the District Court of Haifa advised the court in September 2022 that it intends to seek leave in October 2022 to withdraw its motion for class certification and voluntarily dismiss the action. In Argentina, Intel Argentina was served with, and responded to, a class action complaint in June 2022. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. We dispute the pending claims described above and intend to defend those lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters. </span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VLSI Technology LLC v. Intel</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2017, VLSI Technology LLC (VLSI) filed a complaint against Intel in the U.S. District Court for the Northern District of California alleging infringement of eight patents acquired from NXP Semiconductors, N.V. (NXP). The patents, which originated at Freescale Semiconductor, Inc. and NXP B.V., are U.S. Patent Nos. 7,268,588; 7,675,806; 7,706,207; 7,709,303; 8,004,922; 8,020,014; 8,268,672; and 8,566,836. VLSI accuses various FPGA and processor products of infringement. VLSI estimated its damages to be at least $5.5 billion, and its complaint further sought enhanced damages, future royalties, attorneys’ fees, and costs and interest. In May, June, September, and October 2018, Intel filed Inter Partes Review (IPR) petitions challenging the patentability of claims in all eight of the patents in-suit. The Patent Trial and Appeal Board (PTAB) instituted review of six patents and denied institution on two patents. As a result of the institution decisions, the parties stipulated to stay the District Court action in March 2019. In December 2019 and February 2020, the PTAB found all claims of the '588 and '303 patents, and some claims of the '922 patent, to be unpatentable. The PTAB found the challenged claims of the '014, '672, and '207 patents to be patentable. Intel appealed the PTAB's decision as to '014, '672 and '207 patents. The Federal Circuit affirmed the PTAB's decision as to the '672 and '207 patents, but reversed and remanded as to the '014 patent. Intel moved for a continuation of the stay in March 2020 pending the appeal. In June 2020, the District Court issued an order continuing the stay through August 2021. The court lifted the stay in September 2021, and scheduled a trial for March 2024.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2018, VLSI filed a second suit against Intel, in U.S. District Court for the District of Delaware, alleging infringement by various Intel processors of five additional patents acquired from NXP: U.S. Patent Nos. 6,212,663; 7,246,027; 7,247,552; 7,523,331; and 8,081,026. VLSI accused Intel of willful infringement and seeks an injunction or, in the alternative, ongoing royalties, enhanced damages, attorneys’ fees and costs, and interest. In March 2019, the District Court dismissed VLSI’s claims for willful infringement as to all the patents-in-suit except the ‘027 patent, and also dismissed VLSI’s allegations of indirect infringement as to the ‘633, ‘331, and ‘026 patents. In June 2019, Intel filed IPR petitions challenging the patentability of certain claims in all five patents-in-suit. In January 2020, VLSI said that it was no longer asserting any claims of the ‘633 patent. In January and February 2020, the PTAB instituted review of the '552, '633, '331 and '026 patents, but declined to institute review on the '027 patent. As a result, the District Court stayed the case as to the '026 and '552 patents but allowed the case to proceed on the '027 and '331 patents. In January 2021, the PTAB invalidated certain asserted claims of the ‘026 patent, and in February the PTAB invalidated all asserted claims of the ‘552 patent. Both parties filed notices of appeal regarding the PTAB’s decision as to the ‘026 patent in March 2021, and in April 2021, VLSI filed a notice of appeal of the PTAB's decision as to the '552 patent. The case remains stayed as to both of those patents. For the '027 and '331 patents, VLSI is seeking damages of approximately $4.13 billion plus enhanced damages for the '027 patent. The parties have completed summary judgment and expert witness testimony briefing. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2022, the court granted in part and denied in part Intel’s motion to exclude testimony of VLSI’s technical expert, barring him from testifying regarding Intel’s purported litigation misconduct and the alleged benefits of certain claims of the ‘027 patent. In August 2022, the court stayed the case in light of VLSI's failure to fully disclose its investors pursuant to the court's standing order.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2019, VLSI filed a third suit against Intel, also in U.S. District Court for the District of Delaware, alleging infringement of six more patents acquired from NXP: U.S. Patent Nos. 6,366,522; 6,663,187; 7,292,485; 7,606,983; 7,725,759; and 7,793,025. In April 2019, VLSI voluntarily dismissed this Delaware case without prejudice. In April 2019, VLSI filed three new infringement suits against Intel in the Western District of Texas (WDTX) accusing various Intel processors of infringement. The three suits collectively assert the same six patents from the voluntarily dismissed Delaware case plus two additional patents acquired from NXP, U.S. Patent Nos. 7,523,373 and 8,156,357. VLSI accuses Intel of willful infringement and seeks an injunction or, in the alternative, ongoing royalties, enhanced damages, attorneys’ fees and costs, and interest. In the first Texas case, VLSI asserted the ‘373 and ‘759 patents (in December 2020 the court granted Intel summary judgment of non-infringement on the ‘357 patent, which had also been asserted in the first Texas case). That case went to trial in February 2021, and the jury awarded a “lump sum” to VLSI of $1.5 billion for literal infringement of the ‘373 patent and $675 million for infringement under the doctrine of equivalents of the ‘759 patent. The jury found that Intel had not willfully infringed either patent. Intel challenged the verdict with post-trial motions, including filing in May 2021 a motion for a new trial, which the court denied in August, a motion for judgment as a matter of law that the ‘373 and ‘759 patents are not infringed and the ‘759 patent is invalid, and a motion that VLSI is entitled to no damages, both of which the court denied in March 2022. In April 2022, the court entered final judgment and awarded VLSI $2.175 billion in damages, approximately $162.3 million in pre-judgment interest, and post-judgment interest at the Treasury Bill rate, compounded annually. Intel filed its opening appellate brief in September 2022. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The second Texas case went to trial in April 2021, and the jury found that Intel does not infringe the ‘522 and ‘187 patents. VLSI had sought approximately $3.0 billion for alleged infringement of those patents, plus enhanced damages for willful infringement. The court has not yet entered final judgment following second trial in Texas.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The third Texas case was set for trial in April 2022 but was cancelled after the first day due to a COVID-19 outbreak. A new trial date has been set for November 2022. In that case, VLSI initially sought approximately $2.2 - $2.4 billion for alleged infringement of the ‘983, ‘025 and ‘485 patents, plus enhanced damages for willful infringement. In April 2022, VLSI informed the court that it would not present an infringement case at trial for the '025 patent. Later in April 2022, VLSI informed the court that it would not present willful infringement or an infringement case for the '485 patent at trial. This limits VLSI's damages demand to approximately $1.0 billion for the alleged infringement of the remaining '983 patent. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2019, VLSI filed a case in Shenzhen Intermediate People’s Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserts Chinese Patent 201410094015.9 accusing certain Intel Core processors of infringement. VLSI requests an injunction as well as RMB 1 million in damages and RMB 300 thousand in expenses. Defendants filed an invalidation petition in October 2019 with the CNIPA, which held a hearing in September 2021. The CNIPA has not yet issued a decision. In May 2020, defendants filed a motion to stay the trial court proceedings pending a determination on invalidity. The court held the first evidentiary hearing in November 2020 and the second in July 2021. The court also held trial proceedings in the hearing in July 2021 and concluded that further trial proceedings were needed but indicated those would be stayed pending the outcome of defendants’ invalidity challenge at the CNIPA. In July 2021, VLSI dismissed its case, but refiled it in August 2021. VLSI seeks an injunction in its newly filed case, as well as RMB 1.3 million in reasonable costs and expenses, but no damages. In November 2021, Intel moved for a stay of the August 2021 action pending a ruling on invalidity. The court has not yet ruled on that motion.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2019, VLSI filed a second case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserts Chinese Patent 201080024173.7. VLSI accuses certain Intel Core processors and seeks an injunction, as well as RMB 1 million in damages and RMB 300 thousand in expenses. Defendants filed with the CNIPA an invalidation petition in October 2019, and the CNIPA held a hearing in September 2021, but has not yet issued a decision. In June 2020, defendants filed a motion to stay the trial court proceedings pending a determination on invalidity. The court held its first evidentiary hearing in September 2020. The court held a second evidentiary hearing in December 2020, and a trial the same month. At trial, VLSI dropped its monetary damages claim, but still requested expenses (RMB 300 thousand) and an injunction. The court has not yet issued a decision following the trial. Rather, the court stayed the case in December 2020 pending a determination on invalidity by the CNIPA. In March 2022, the CNIPA issued an order holding the claims of the patent to be valid. The court held a second trial in May 2022 following the CNIPA ruling, but has yet to issue its final decision.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2019, Intel, along with Apple Inc., filed a complaint against Fortress Investment Group LLC, Fortress Credit Co. LLC, Uniloc 2017 LLC, Uniloc USA, Inc., Uniloc Luxembourg S.A.R.L., VLSI, INVT SPE LLC, Inventergy Global, Inc., DSS Technology Management, Inc., IXI IP, LLC, and Seven Networks, LLC. Plaintiffs allege violations of Section 1 of the Sherman Act by certain defendants, Section 7 of the Clayton Act by certain defendants, and California Business and Professions Code section 17200 by all defendants based on defendants' unlawful aggregation of patents. In 2020 and 2021, the court twice dismissed plaintiffs' complaint with leave to amend. In December 2020, the court granted a joint motion by Apple and Seven Networks to dismiss with prejudice Apple’s claims against Seven Networks. Plaintiffs filed a second amended complaint in March 2021. Defendants moved to dismiss the Second Amended Complaint in May 2021. Apple withdrew from the case and dismissed its claims in June 2021. The court heard defendants’ motion to dismiss the Second Amended Complaint in September 2021, and dismissed Intel’s claims with prejudice that same month, entering judgment in favor of defendants. Intel filed a notice of appeal in December 2021. Appellate briefing concluded in June 2022 and oral argument was held in October 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2020, affiliates controlled by Fortress Investment Group, which also controls VLSI, acquired Finjan Holdings, Inc. Intel had signed a “Settlement, Release and Patent License Agreement” with Finjan in 2012, acquiring a license to the patents of Finjan and its affiliates, current or future, through a capture period of November 20, 2022. The agreement also contains covenants wherein Finjan agrees to cause its affiliates to comply with the agreement. As such, Intel maintains that it now has a license to the patents of VLSI, which has become a Finjan affiliate, and that Finjan must cause VLSI to dismiss its suits against Intel. In August 2020, Intel started dispute resolution proceedings under the agreement. As a part of this dispute resolution process, Intel and Finjan held a mediation in December 2020, but failed to resolve their differences. Intel filed suit to enforce its rights under the License Agreement with Finjan in January 2021 in Delaware Chancery Court. In March 2021, defendants filed motions to dismiss the Chancery Court proceedings. The court heard those motions in May 2021, and dismissed all of Intel’s claims—except the breach of contract claim—with prejudice in September 2021 for lack of jurisdiction because, the court reasoned, Intel’s license defense has been raised in the other U.S. suits between Intel and VLSI and could be adjudicated in one of those actions. The court stayed Intel’s breach of contract claim pending a determination on whether Intel is licensed to VLSI’s patents. In September 2020, Intel filed motions to stay the Texas, Delaware, and Shanghai matters pending resolution of its dispute with Finjan. In November 2020, Intel filed a motion to stay the Shenzhen matter pending resolution of its dispute with Finjan. In November 2020, the Delaware Court denied Intel’s motion to stay. The other stay motions remain pending. Finally, Intel filed a motion to amend its answer in the Texas matters to add a license defense in November 2020, and filed a motion to amend its answer in the Delaware matter to add a license defense in February 2021. The Delaware Court granted Intel's motion in July 2021, but in March 2022, the Texas Court denied Intel's motion, holding, among other things, that it would be futile for Intel to add the license defense as it would not be meritorious. Intel has appealed this ruling as a part of its appeal of the verdict in the first VLSI Texas trial.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October and November 2019, and in February 2020, Intel filed IPR petitions on certain asserted claims across six of the patents-in-suit in WDTX. Between May and October 2020, the PTAB denied all of these petitions on a discretionary basis and without reviewing the merits. Intel requested a rehearing, and review from the POP as to all petitions. All requests for POP review and rehearing were denied. Intel filed notices of appeal regarding the discretionary denials for all petitions in February and March of 2021. The Federal Circuit dismissed the appeals in May 2021 for lack of jurisdiction. The Federal Circuit denied Intel’s petition for hearing en banc in August 2021. In March 2022, the Supreme Court denied Intel’s petition for writ of certiorari.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2021, OpenSky Industries LLC (OpenSky) requested IPR of certain claims of the '373 and '759 patents at-issue in the first Texas case, including those claims found to be infringed in that judgment. Both petitions copied Intel's earlier petitions, and used the expert declarations previously submitted by Intel. Another entity named Patent Quality Assurance LLC (PQA) also petitioned for IPR of certain claims of the '373 patent, those claims found to be infringed in the first Texas case judgment. PQA also largely copied Intel's petition, but (1) added a challenge to an additional claim and (2) included newly signed declarations from Intel's experts. In December 2021, the PTAB instituted OpenSky's petition on the '759 patent, but declined to institute on the '373 patent. In December 2021, Intel filed a motion to join OpenSky's '759 IPR. In January 2022, the PTAB instituted PQA's petition on the '373 patent. In February, Intel filed a motion to join PQA's petition. Both of Intel's joinder motions were granted in June 2022, allowing Intel to participate in the IPRs. Hearings were held in September 2022 for the OpenSky petition and in October 2022 for the PQA petition. PTAB decisions are expected in December 2022 on the '759 patent, and January 2023 on the '373 patent. At the same time, the Director of the United States Patent &amp; Trademark Office is reviewing both the OpenSky and PQA IPRs to determine if they should be allowed to proceed to final written decisions. The Director has said that that process may delay the final written decision of the '759 patent IPR, but has not made any similar statement regarding the timeline for the '373 patent IPR. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">After consideration of the verdicts in the WDTX cases and the additional pending lawsuits filed by VLSI, Intel accrued a charge of $2.2 billion in the first quarter of 2021 and anticipates losses, if any, in excess of this amount would be immaterial to the financial statements. We dispute VLSI’s claims and intend to vigorously defend against them.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation Related to 7nm Product Delay Announcement</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Starting in July 2020, five securities class action lawsuits were filed in the United States District Court for the Northern District of California against Intel and certain current and former officers based on Intel’s July 2020 announcement of 7nm product delays. The plaintiffs, who purport to represent classes of acquirers of Intel stock between October 2019 and July 2020, generally allege that the defendants violated securities laws by making false or misleading statements about the timeline for 7nm products in light of subsequently announced delays. In October 2020, the court consolidated the lawsuits, appointed lead plaintiffs, and in January 2021 the lead plaintiffs filed a consolidated complaint. Defendants moved to dismiss the consolidated complaint in March 2021. We dispute the claims described above and intend to defend the lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters. In July 2021, Intel introduced a new process node naming structure, and the 7nm process is now Intel 4.</span></div>

Files In Submission

Name View Source Status
intc-20221001_lab.xml Edgar Link unprocessable
intc-20221001_cal.xml Edgar Link unprocessable
0000050863-22-000038-index-headers.html Edgar Link pending
0000050863-22-000038-index.html Edgar Link pending
0000050863-22-000038.txt Edgar Link pending
0000050863-22-000038-xbrl.zip Edgar Link pending
a10012022ex103.htm Edgar Link pending
a10012022ex311.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
intc-20221001_pre.xml Edgar Link unprocessable
a10012022ex312.htm Edgar Link pending
a10012022ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
intc-20221001.htm Edgar Link pending
intc-20221001.xsd Edgar Link pending
intc-20221001_g1.jpg Edgar Link pending
intc-20221001_g10.jpg Edgar Link pending
intc-20221001_g11.jpg Edgar Link pending
intc-20221001_g12.jpg Edgar Link pending
intc-20221001_g13.jpg Edgar Link pending
intc-20221001_g14.jpg Edgar Link pending
intc-20221001_g15.jpg Edgar Link pending
intc-20221001_g16.jpg Edgar Link pending
intc-20221001_g17.jpg Edgar Link pending
intc-20221001_g18.jpg Edgar Link pending
intc-20221001_g19.jpg Edgar Link pending
intc-20221001_g2.jpg Edgar Link pending
intc-20221001_g20.jpg Edgar Link pending
intc-20221001_g21.jpg Edgar Link pending
intc-20221001_g22.jpg Edgar Link pending
intc-20221001_g23.jpg Edgar Link pending
intc-20221001_g24.jpg Edgar Link pending
intc-20221001_g25.jpg Edgar Link pending
intc-20221001_g26.jpg Edgar Link pending
intc-20221001_g27.jpg Edgar Link pending
intc-20221001_g28.jpg Edgar Link pending
intc-20221001_g29.jpg Edgar Link pending
intc-20221001_g3.jpg Edgar Link pending
intc-20221001_g4.jpg Edgar Link pending
intc-20221001_g5.jpg Edgar Link pending
intc-20221001_g6.jpg Edgar Link pending
intc-20221001_g7.jpg Edgar Link pending
intc-20221001_g8.jpg Edgar Link pending
intc-20221001_g9.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
intc-20221001_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
intc-20221001_def.xml Edgar Link unprocessable